ESRRB inhibits the TGF-beta signaling pathway to drive cell proliferation in cervical cancer. Li QS, Zheng PS. Cancer Res 2023 Jun 23:CAN-23-0067. doi: 10.1158/0008-5472.CAN-23-0067.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li QS, Zheng PS. ESRRB inhibits the TGF-beta signaling pathway to drive cell proliferation in cervical cancer. Cancer Res 2023 Jun 23:CAN-23-0067. doi: 10.1158/0008-5472.CAN-23-0067.
PMID: 37350664